Literature DB >> 24292148

Molecular evaluation of proliferative-phase endometrium may provide insight about the underlying causes of infertility in women with endometriosis.

Bradley S Hurst1, Kathleen E Shimp, Mollie Elliot, Paul B Marshburn, Judy Parsons, Zahra Bahrani-Mostafavi.   

Abstract

PURPOSE: To determine if endometrial gene expression is different in women with endometriosis-related infertility and fertile women.
METHODS: Prospective study of mid-follicular phase endometrium in 47 subjects in two phases: microarray study of 10 infertile women with endometriosis and five fertile controls, and a quantitative real-time PCR (qRT-PCR) study of 27 infertile women with endometriosis and 15 fertile controls. Gene expression was determined by DNA microarray, and qRT-PCR used for 12 "promising" genes based on the microarray analysis.
RESULTS: Compared to fertile controls, women with stage I-II endometriosis had 23, and women with stage III-IV had 35 genes that were significantly up- or down-regulated by microarray. However, using qRT-PCR, only chemokine ligand (CXCL) 13 was significantly down-regulated and somatostatin was significantly up-regulated with early endometriosis, and only CXCL 14 was significantly down-regulated with advanced endometriosis compared to fertile controls.
CONCLUSIONS: Our findings indicate that the pattern of gene expression in proliferative-phase endometrium is different when comparing tissue from patients with endometriosis versus fertile controls. Recognition of these endometrial alterations could be helpful to diagnose and stage endometriosis, and may provide insight to explain why conception rates are low in women with endometriosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292148     DOI: 10.1007/s00404-013-3103-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

Review 1.  MicroRNAs in endometriosis: biological function and emerging biomarker candidates†.

Authors:  Sarah Bjorkman; Hugh S Taylor
Journal:  Biol Reprod       Date:  2019-05-01       Impact factor: 4.285

Review 2.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

3.  H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis.

Authors:  Sanaz Ghazal; Brett McKinnon; Jichun Zhou; Martin Mueller; Yi Men; Lihua Yang; Michael Mueller; Clare Flannery; Yingqun Huang; Hugh S Taylor
Journal:  EMBO Mol Med       Date:  2015-08       Impact factor: 12.137

4.  Identification of Circular RNAs as a Novel Biomarker for Ovarian Endometriosis.

Authors:  Xiao-Xuan Xu; Shuang-Zheng Jia; Yi Dai; Jun-Ji Zhang; Xiao-Yan Li; Jing-Hua Shi; Jin-Hua Leng; Jing-He Lang
Journal:  Chin Med J (Engl)       Date:  2018-03-05       Impact factor: 2.628

Review 5.  Bowel Endometriosis: Current Perspectives on Diagnosis and Treatment.

Authors:  Nassir Habib; Gabriele Centini; Lucia Lazzeri; Nicola Amoruso; Lionel El Khoury; Errico Zupi; Karolina Afors
Journal:  Int J Womens Health       Date:  2020-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.